Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population

Therapeutic Drug Monitoring

Volumn 26, Issue 3, 2004, Pages 319-321

  Kubota, Takahiro ^a   Nishida, Akihito ^a   Takeuchi, Ken ^b   Iida, Takayuki ^b   Yokota, Hiromitsu ^a   Higashi, Katsumi ^a   Nakahara, Kazuhiko ^a   Hanai, Hiroyuki ^b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 mercaptopurine; Genetic polymorphism; Japanese; Red blood cells; Thiopurine S methyltransferase

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

ADULT; ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

6-MERCAPTOPURINE; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; METHYLATION; METHYLTRANSFERASES; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 2542596944     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200406000-00017     Document Type: Article

References (19)

1. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: Monogenetics: inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32:651-662.
2. Anstey S, Lennard L, Mayou SC, et al. Pancytopenia related to azathioprine-an enzyme deficiency caused by a common genetic polymorphism. J R Soc Med. 1992;85:752-756.
3. McLeod HL, Lin JS, Scott EP, et al. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther. 1994;55:15-20.
4. McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus-implications for clinical pharmacogenomics. Pharmacogenomics. 2002;3:89-98.
5. Holme SA, Duley JA, Sanderson J, et al. Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. Q J Med. 2002;95:439-444.
6. O'Kane DJ, Weinshilboum RM, Moyer TP. Pharmacogenomics and reducing the frequency of adverse drug events. Pharmacogenomics. 2003;4:1-4.
7. Kröplin T, Iven H. Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase. A comparison of activity in red blood cell samples of 199 blood donors. Eur J Clin Pharmacol. 2000;56:343-345.
8. Rossi AM, Bianchi M, Guamieri C, et al. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol. 2001;57:51-54.
9. Lowenthal A, Meyerstein N, Ben-Zvi Z. Thiopurine methyltransferase activity in the Jewish population of Israel. Eur J Clin Pharmacol. 2001;57:43-46.
10. Chang JG, Lee LS, Chen CM, et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics. 2002;12:191-195.
11. Nishida A, Kubota T, Yamada Y, et al. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes. Clin Chim Acta. 2002;323:147-150.
12. Kubota T, Chiba K. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B, *3C) in 151 healthy Japanese subjects and inheritance of TPMT*3C in the family of a propositus. Br J Clin Pharmacol. 2001;51:475-477.
13. Hiratsuka M, Inoue T, Omori F, et al. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res. 2000;448:91-95.
14. Kumagai K, Hiyama K, Ishioka S, et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics. 2001;11:275-278.
15. Tai H-L, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant alleles associated with loss of catalytic activity in Caucasians. Am J Hum Genet. 1996;58:694-702.
16. Tai H-L, Krynetski EY, Schuetz EG, et al. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): Mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA. 1997;94:6444-6449.
17. Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther. 1997;62:60-73.
18. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathiopurine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608-614.
19. Loennenchen T, Yates CR, Fessing MY, et al. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans. Clin Pharmacol Ther. 1998;64:46-51.